###begin article-title 0
Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy
###end article-title 0
###begin p 1
###xml 31 61 31 61 <email xmlns:xlink="http://www.w3.org/1999/xlink">hayashi@dent.tokushima-u.ac.jp</email>
CORRESPONDENCE Yashio Hayashi: hayashi@dent.tokushima-u.ac.jp
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 498 499 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 861 864 853 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 857 864 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2<sup>&#8722;/&#8722;</sup></italic>
###xml 935 941 927 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 76 81 <span type="species:ncbi:9606">women</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
Although several autoimmune diseases are known to develop in postmenopausal women, the mechanisms by which estrogen deficiency influences autoimmunity remain unclear. Recently, we found that retinoblastoma-associated protein 48 (RbAp48) induces tissue-specific apoptosis in the exocrine glands depending on the level of estrogen deficiency. In this study, we report that transgenic (Tg) expression of RbAp48 resulted in the development of autoimmune exocrinopathy resembling Sjogren's syndrome. CD4+ T cell-mediated autoimmune lesions were aggravated with age, in association with autoantibody productions. Surprisingly, we obtained evidence that salivary and lacrimal epithelial cells can produce interferon-gamma (IFN-gamma) in addition to interleukin-18, which activates IFN regulatory factor-1 and class II transactivator. Indeed, autoimmune lesions in Rag2-/- mice were induced by the adoptive transfer of lymph node T cells from RbAp48-Tg mice. These results indicate a novel immunocompetent role of epithelial cells that can produce IFN-gamma, resulting in loss of local tolerance before developing gender-based autoimmunity.
###end p 3
###begin p 4
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
Abbreviations used: CIITA, class II transactivator; cLN, cervical LN; HSG, human salivary gland; IRF, IFN regulatory factor; MSG, mouse salivary gland; NOD, nonobese diabetic; RA, rheumatoid arthritis; RbAp48, retinoblastoma-associated protein 48; SLE, systemic lupus erythematosus; SS, Sjogren's syndrome; Tg, transgenic.
###end p 4
###begin p 5
N. Ishimura and R. Arakaki contributed equally to this paper.
###end p 5
###begin p 6
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
Autoimmune disease is controlled by environments that include gene variants or various cytokines (1, 2). It can increase susceptibility to autoimmunity by affecting the overall reactivity and quality of the cells of the immune system. There is an autoimmune disease specific for certain organs in the body, involving a response to an antigen expressed only in those organs. Antigen/organ specificity is affected by antigen presentation and recognition, antigen expression, and the state and response of the target organs (3, 4), which are maintained by a local immune system termed here "local tolerance."
###end p 6
###begin p 7
###xml 285 286 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 435 436 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 659 660 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 732 733 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 734 735 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 911 912 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 922 924 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 926 928 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1173 1174 1170 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2002 2004 1996 1998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 2006 2008 2000 2002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 2067 2069 2061 2063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 518 523 <span type="species:ncbi:9606">human</span>
Many mechanisms protect tissues from autoimmune damage. These include relative isolation from the immune system and inhibition of the function of invading lymphocytes. For example, the eye has barriers to T cell infiltration and produces immunosuppressive cytokines, such as TGF-beta (5). Constitutive expression of Fas ligand within the privileged site might also prevent immune-mediated damage by eliminating Fas-expressing T cells (6). Although they have yet to be well demonstrated in spontaneous animal models or human disease, genetic effects at the level of tissue protection are therefore to be expected. Autoimmune organ damage can be mediated by CD4+ T cells, which play a crucial role in the development of autoimmunity (7-9). MHC class II alleles are probably involved in autoimmune disease because different alleles have different abilities to present peptides from target cells to autoreactive CD4+ T cells (10, 11). Certain class II alleles might predispose to autoimmunity by increasing positive selection or decreasing negative selection of autoreactive T cells in the thymus. They might also act by inhibiting selection in the thymus of the regulatory CD4+ T cells that are thought to prevent autoantigen-specific responses. Evidence for the local tolerance hypothesis is provided by the observation that autoimmune diseases are often tissue specific and sometimes involve antibodies against a restricted set of antigens, thereby prompting us to accept this most simple explanation for the initiation of autoimmunity. The loss of local tolerance is considered to result from the combined effect of different environmental factors. MHC class II genes are constitutively expressed only on hematopoietic cells involved in antigen presentation (dendritic cells, macrophages, B cells, and cortical thymic epithelial cells), but can be aberrantly induced by inflammatory stimuli on many other cell types (such as endothelial cells, hepatocytes, beta cells of the pancreas, and thyrocytes) (12, 13). Although it has been implicated in allograft rejection (14), and subsequently in autoimmunity, it is still unknown whether to initiate autoimmunity class II molecules have to be expressed on professional APCs within secondary lymphoid organs or on nonhematopoietic cells of the target organ itself.
###end p 7
###begin p 8
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 497 503 <span type="species:ncbi:10090">murine</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 1076 1081 <span type="species:ncbi:10090">mouse</span>
It has been suggested that estrogenic action is responsible for the strong female preponderance of many autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sjogren's syndrome (SS) (15, 16). Recent evidence suggests that apoptosis plays a key role in the physiology and pathogenesis of various autoimmune diseases, including SS (17-21). We have demonstrated that estrogenic action influences target epithelial cells through Fas-mediated apoptosis in a murine model for SS (21). Recently, we found that tissue-specific apoptosis in the exocrine glands spontaneously occurring in estrogen-deficient mice may contribute to the development of autoimmune exocrinopathy (22). Searching for the role of estrogen deficiency in the development of autoimmunity, we have recently identified retinoblastoma-associated protein 48 (RbAp48) gene specific for estrogen deficiency-dependent apoptosis in the exocrine glands, and transgenic expression of RbAp48 gene induced tissue-specific apoptosis in the exocrine glands (23). In this transgenic mouse model, we propose a possible clear and defined ab initio relationship between aberrant exposure of MHC class II molecules on IFN-gamma-producing epithelial cells and disease development (i.e., autoimmune exocrinopathy).
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Autoimmune exocrinopathy develops in RbAp48-transgenic (Tg) mice
###end title 10
###begin p 11
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 422 428 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 492 500 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 890 896 878 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 919 927 907 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 986 992 974 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1078 1079 1066 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1083 1084 1071 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1128 1129 1116 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1142 1143 1130 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1153 1161 1141 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1173 1174 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1267 1273 1255 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1346 1352 1334 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1438 1446 1426 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 1494 1500 1482 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1541 1545 1529 1533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1552 1555 1540 1543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1563 1566 1551 1554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1592 1593 1580 1581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1630 1636 1618 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1680 1688 1668 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1760 1761 1748 1749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1764 1765 1752 1753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1795 1798 1783 1786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1875 1876 1863 1864 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1880 1881 1868 1869 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1886 1887 1874 1875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1964 1970 1952 1958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2098 2104 2083 2089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2213 2219 2194 2200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2258 2266 2239 2247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 2375 2377 2352 2354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 2379 2381 2356 2358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 2529 2535 2502 2508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2585 2593 2558 2566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 2699 2700 2672 2673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2704 2705 2677 2678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2751 2753 2724 2726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 2790 2796 2763 2769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2828 2836 2801 2809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 2865 2866 2838 2839 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2870 2871 2843 2844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2938 2944 2911 2917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 3007 3011 2980 2984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 3014 3018 2987 2991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 3022 3023 2995 2996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 3105 3111 3078 3084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
###xml 1277 1281 <span type="species:ncbi:10090">mice</span>
###xml 1356 1360 <span type="species:ncbi:10090">mice</span>
###xml 1504 1508 <span type="species:ncbi:10090">mice</span>
###xml 1640 1644 <span type="species:ncbi:10090">mice</span>
###xml 1674 1678 <span type="species:ncbi:10090">mice</span>
###xml 1817 1821 <span type="species:ncbi:10090">mice</span>
###xml 1981 1985 <span type="species:ncbi:10090">mice</span>
###xml 2108 2112 <span type="species:ncbi:10090">mice</span>
###xml 2230 2234 <span type="species:ncbi:10090">mice</span>
###xml 2354 2360 <span type="species:ncbi:10090">murine</span>
###xml 2365 2370 <span type="species:ncbi:9606">human</span>
###xml 2539 2543 <span type="species:ncbi:10090">mice</span>
###xml 2570 2574 <span type="species:ncbi:10090">mice</span>
###xml 2800 2804 <span type="species:ncbi:10090">mice</span>
###xml 2822 2826 <span type="species:ncbi:10090">mice</span>
###xml 2948 2952 <span type="species:ncbi:10090">mice</span>
###xml 3115 3119 <span type="species:ncbi:10090">mice</span>
###xml 3148 3152 <span type="species:ncbi:10090">mice</span>
We have generated RbAp48-Tg mice where the RbAp48 gene is expressed in the salivary and lacrimal glands using the salivary gland-specific promoter (23). When the histopathology of all organs from those mice were analyzed, we found that autoimmune exocrinopathy resembling SS developed in almost all RbAp48-Tg mice at 24 wk of age or more, but not in the WT mice. Lymphocyte infiltration in salivary and lacrimal glands of RbAp48-Tg mice becomes more frequent at approximately30-50 wk of age (Fig. 1 A), and a significantly higher incidence of inflammatory lesions was found in female Tg mice at all ages (not depicted). Many infiltrating lymphocytes were observed in periductal areas at moderate (score 2) to severe (score 4) degrees, and shown in focal appearance. Representative histopathological features of the inflammatory lesions in lachrymal and salivary (submandibular) glands from RbAp48-Tg mice were shown in Fig. 1 B. No inflammatory lesions were observed in other organs of RbAp48-Tg mice. A majority of infiltrating cells in salivary and lacrimal glands were Thy1.2+ CD4+ T cells, whereas a minor proportion of B220+ B cells, CD8+ T cells (Fig. 1 C), and CD11b+ cells (unpublished data) was observed. When the function of lacrimal and salivary glands in RbAp48-Tg mice was analyzed, the mean volume of tear and saliva secretion from RbAp48-Tg mice was significantly lower than that from the WT group at 30 wk of age or more (Fig. 1 D). Regarding the peripheral T cell phenotype of RbAp48-Tg mice, T cell activation markers (CD44high, CD62Llow, CD45RBlow) were up-regulated on CD4+ T cells in cervical LNs (cLNs) from RbAp48-Tg mice, compared with those from WT mice (Fig. 2 A). No significant difference was observed in thymic T cells gated on CD4+CD8- bearing CD69, CD25, and CD62Llow between Tg and WT mice (Fig. S1, available at ). As for the phenotype of CD4+CD25+Foxp3+ T reg cells, no difference was detected in thymus, spleen, and cLNs between RbAp48-Tg and WT mice (Fig. S2). Moreover, culture supernatants from anti-TCR-beta and -CD28 mAb-stimulated cLN T cells obtained from RbAp48-Tg mice contained higher levels of IL-2 and IFN-gamma, whereas no difference in IL-4 and -10 levels between RbAp48-Tg and WT mice was observed by ELISA (Fig. 2 B). Our previous reports identified a 120-kD alpha-fodrin as an important autoantigen in murine and human SS (24, 25). It is particularly interesting that a higher titer of serum autoantibodies against SS-A (Ro), SS-B (La), and 120-kD alpha-fodrin was detected in RbAp48-Tg mice, compared with that in WT mice by ELISA (Fig. 2 C). This result is consistent with the characteristic flow cytometric finding that showed a significant CD5+B220+ fraction capable of autoantibody production (26) that appeared in spleen cells from RbAp48-Tg mice compared with WT mice (Fig. 2 D). On the other hand, the CD5+B220+ cells were undetectable in both salivary and lacrimal glands from RbAp48-Tg mice (Fig. S3 A). In addition, significantly increased CD21highIgMhighB220+ marginal zone B cells were observed in both cervical lymph nodes and spleen from RbAp48-Tg mice compared with those from WT mice (Fig. S3). These results may provide a new animal model for autoimmune exocrinopathy resembling SS, which should help us to further understand how autoreactive T cells are developed, and subsequently influence the development of autoimmunity.
###end p 11
###begin p 12
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Autoimmune lesions in <italic>RbAp48</italic>-Tg mice.</bold>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 356 357 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 614 620 614 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
Autoimmune lesions in RbAp48-Tg mice. (A) Mean grade of inflammatory lesions in salivary and lacrimal glands from WT and RbAp48-Tg mice 10-50 wk of age. (B) Images (H&E staining) are representative of 5-7 mice at 32 wk of age. (C) Lymphocyte populations of the salivary gland lesion from RbAp48-Tg mice at 24 wk of age. Thy1.2+, CD4+, CD8+ T cells, or B220+ B cells were detected by immunofluorescence staining with FITC- (green) or PE-conjugated (red) mAbs using the frozen sections. Images are representative of three to five samples from each group. (D) The mean volume of saliva and tear secretion from WT and RbAp48-Tg mice at 30 wk of age was measured. Data are means +/- SE of five mice. The results are representative of two independent experiments. Bars: (B) 100 mum; (C) 40 mum.
###end p 12
###begin p 13
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immune responses in <italic>RbAp48</italic>-Tg mice.</bold>
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 189 195 189 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 478 484 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
Immune responses in RbAp48-Tg mice. (A and B) Activation markers and cytokine production of CD4+ T cells of cLNs from WT and RbAp48-Tg mice at 32 wk of age. (C) Autoantibodies of sera from RbAp48-Tg mice at 28-32 wk of age. (D) CD5+B220+ population of spleen from RbAp48-Tg and WT mice at 20 and 40 wk of age was analyzed by flow cytometry. Results are representative of means +/- SE of five to seven mice in three independent experiments. *, P < 0.05; **, P < 0.005; WT versus RbAp48-Tg mice.
###end p 13
###begin title 14
Salivary gland epithelial cells function as APCs
###end title 14
###begin p 15
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 337 345 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 892 893 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 899 900 899 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 912 913 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 931 932 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1013 1021 1013 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 1367 1368 1367 1368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1526 1534 1526 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 1568 1569 1568 1569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1575 1576 1575 1576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1582 1583 1582 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1595 1596 1595 1596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1632 1638 1632 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1689 1697 1689 1697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1836 1842 1836 1842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1940 1941 1940 1941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1945 1946 1945 1946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1961 1967 1961 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2025 2026 2025 2026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 2068 2069 2068 2069 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2124 2130 2124 2130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2148 2149 2148 2149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2163 2169 2163 2169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2223 2229 2223 2229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2333 2341 2333 2341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 2384 2385 2384 2385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 2441 2442 2441 2442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2464 2470 2464 2470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2525 2531 2525 2531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2572 2580 2572 2580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 2645 2646 2645 2646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2678 2684 2678 2684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2738 2746 2738 2746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 2797 2798 2797 2798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 2808 2814 2808 2814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2862 2863 2862 2863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 2892 2907 2892 2907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B and C</xref>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 574 579 <span type="species:ncbi:10090">mouse</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
###xml 1642 1646 <span type="species:ncbi:10090">mice</span>
###xml 1846 1850 <span type="species:ncbi:10090">mice</span>
###xml 1971 1975 <span type="species:ncbi:10090">mice</span>
###xml 2039 2043 <span type="species:ncbi:10090">mice</span>
###xml 2050 2054 <span type="species:ncbi:10090">mice</span>
###xml 2086 2090 <span type="species:ncbi:10090">mice</span>
###xml 2173 2177 <span type="species:ncbi:10090">mice</span>
###xml 2233 2237 <span type="species:ncbi:10090">mice</span>
###xml 2266 2270 <span type="species:ncbi:10090">mice</span>
###xml 2474 2478 <span type="species:ncbi:10090">mice</span>
###xml 2535 2539 <span type="species:ncbi:10090">mice</span>
###xml 2566 2570 <span type="species:ncbi:10090">mice</span>
###xml 2688 2692 <span type="species:ncbi:10090">mice</span>
###xml 2732 2736 <span type="species:ncbi:10090">mice</span>
###xml 2818 2822 <span type="species:ncbi:10090">mice</span>
###xml 2886 2890 <span type="species:ncbi:10090">mice</span>
It is well known that nonlymphoid cells that express MHC class II molecules provoke autoimmune responses (12, 13). However, it is undetermined whether MHC class II-expressing epithelial cells can function as APCs. We frequently observed MHC class II molecule expression on the exocrine gland cells in RbAp48-Tg mice, but not in WT mice (Fig. 3 A). These molecules play a pivotal role in the induction and regulation of immune responses by virtue of their ability to present self-peptides to CD4+ T cells (27). To examine whether salivary epithelial cells could act as APCs, mouse salivary gland (MSG) cells, splenocytes, and splenic CD11c+ DCs from RbAp48-Tg mice and WT mice were compared in terms of their capacity to express MHC class II and costimulatory molecules, including CD86, CD80, and ICAM-1, by flow cytometric analysis. Among them, a considerably large proportion of MHC class II+, CD86+ cells, CD80+ cells, and ICAM-1+ cells was observed on MSG cells from Tg mice, compared with those from WT mice (Fig. 3 B). MSG cells were enriched by enzymatic treatment and using several antibodies against immune cells, epithelial cells, and magnetic beads, as shown in Fig. S4 A (available at ). DCs were undetectable in the purified MSG cell suspension (Fig. S4 B). On the other hand, although the expressions of MHC class II and CD86 on the splenocytes and CD11c+ DCs were higher than those on both MSG cells, the expressions of CD80 and ICAM-1 on the professional APCs were similar or lower than those on the MSG cells (Fig. 3 B). These expressions (MHC class II+, CD86+, CD80+, and ICAM-1+) on salivary epithelial cells from RbAp48-Tg mice were also confirmed by confocal analysis (Fig. 3 C). Controls using isotype antibodies for immunostainings were shown in Fig. S4 B. Moreover, to examine whether the peripheral T cells from RbAp48-Tg mice can respond to the MSG cells that show phenotypes for the APCs, CFSE-labeled purified CD4+ (105) T cells from RbAp48-Tg mice were co-cultured with the MSG cells (1 and 2 x 105) from those mice or WT mice. Although CD4+ T cells from B6 mice could not respond to both B6 and RbAp48-Tg MSG cells, CD4+ T cells from RbAp48-Tg mice were capable of responding to MSG cells from RbAp48-Tg mice, but not with those from WT mice, whereas anti-MHC class II antibody inhibits these responses (Fig. 4 A). Furthermore, proliferation assay using [3H]thymidine incorporation demonstrated that purified CD4+ T cells of cLNs from RbAp48-Tg mice were more proliferative to the MSG cells from RbAp48-Tg mice relative to those from WT mice (Fig. 4 B). Additionally, significantly increased proliferation of the CD4+ T cells to peripheral DCs from RbAp48-Tg mice was observed compared with DCs from WT mice (Fig. 4 C). Approximately half of the T cells response to 105 DCs from RbAp48-Tg mice equaled the level of the response to 105 MSG cells from the Tg mice (Fig. 4, B and C).
###end p 15
###begin p 16
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Antigen-presenting function in salivary epithelial cells.</bold>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 228 231 <span type="species:ncbi:10116">rat</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 699 702 <span type="species:ncbi:10116">rat</span>
###xml 746 752 <span type="species:ncbi:9986">rabbit</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
Antigen-presenting function in salivary epithelial cells. (A) MHC class II expression of salivary tissues from WT and RbAp48-Tg mice was detected by confocal analysis using anti-MHC class II mAb, Alexa Fluor 568-conjugated anti-rat IgG (red) and DAPI (blue). Images are representative of five to seven mice. (B) APC markers of splenocytes, splenic DCs, and MSG cells from WT and RbAp48-Tg mice were analyzed by flow cytometer. Results are representative of three to five mice in two independent experiments. (C) APC markers of MSG epithelial cells were detected by confocal analysis using anti-MHC class II, CD86, CD80, ICAM-1 mAbs, anti-keratin polyclonal antibody, Alexa Fluor 568-conjugated anti-rat IgG (red), Alexa Fluor 488-conjugated anti-rabbit IgG (green), and DAPI (blue). Images are representative of five to seven mice. Bars: (A and C) 50 mum.
###end p 16
###begin p 17
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+</sup> T cells can proliferate to epithelial cells from <italic>RbAp48</italic>-Tg mice.</bold>
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp4</italic>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 466 467 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 483 484 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 499 505 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 567 568 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 582 588 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 614 615 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 631 632 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 647 653 646 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 709 710 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 724 730 723 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 797 798 796 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 989 995 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
CD4+ T cells can proliferate to epithelial cells from RbAp48-Tg mice. (A) CFSE-labeled purified CD4+ T cells (105) of WT and RbAp48-Tg mice were co-cultured with MSG cells (1 and 2 x 105) from the mice for 72 h. Cell proliferation was estimated by the dilution of CFSE. 2 mug/ml anti-MHC class II mAb or isotype control antibody was added in the culture. All results are representative of three to five mice at 28 wk of age, or three-independent experiments. (B) CD4+ T cells (5 x 104) of cLNs from RbAp48-Tg mice were co-cultured with irradiated MSG cells (0-10 x 104) from WT and RbAp48-Tg mice for 72 h. (C) CD4+ T cells (5 x 104) of cLNs from RbAp48-Tg mice were co-cultured with irradiated DCs (0-10 x 104) from WT and RbAp48-Tg mice for 72 h. Proliferative T cell response was evaluated by [3H]thymidine incorporation during the last 12 h of the culture. Results are representative of means +/- SE of triplicates in two independent experiments. *, P < 0.05; **, P < 0.005; WT versus RbAp48-Tg MSG cells or DCs.
###end p 17
###begin title 18
Crucial role of epithelial IFN-gamma production
###end title 18
###begin p 19
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 369 371 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 434 436 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 603 605 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 632 638 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 677 685 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 837 843 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 976 982 964 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1041 1049 1025 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 1069 1075 1053 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1228 1234 1208 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1257 1265 1237 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 1323 1324 1303 1304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1435 1441 1411 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1715 1717 1687 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1822 1824 1790 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 1861 1863 1829 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 1928 1934 1896 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1960 1968 1928 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 2182 2188 2142 2148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2220 2228 2180 2188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 2408 2414 2364 2370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2537 2543 2489 2495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2553 2561 2505 2513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 2655 2657 2607 2609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 2983 2989 2919 2925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 3275 3281 3199 3205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 3336 3344 3260 3268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 3483 3489 3403 3409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 3691 3697 3607 3613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 3820 3826 3733 3739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 3832 3840 3745 3753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 3964 3970 3873 3879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 3972 3980 3881 3889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 4127 4133 4032 4038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 4276 4278 4177 4179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 4279 4281 4180 4182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 4492 4500 4389 4397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 4642 4650 4535 4543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 4758 4764 4651 4657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 4804 4812 4697 4705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 E</xref>
###xml 4971 4973 4864 4866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 4998 5004 4891 4897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 5037 5039 4930 4932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1238 1242 <span type="species:ncbi:10090">mice</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
###xml 1445 1449 <span type="species:ncbi:10090">mice</span>
###xml 1938 1942 <span type="species:ncbi:10090">mice</span>
###xml 1954 1958 <span type="species:ncbi:10090">mice</span>
###xml 2192 2196 <span type="species:ncbi:10090">mice</span>
###xml 2214 2218 <span type="species:ncbi:10090">mice</span>
###xml 2431 2435 <span type="species:ncbi:10090">mice</span>
###xml 2547 2551 <span type="species:ncbi:10090">mice</span>
###xml 2993 2997 <span type="species:ncbi:10090">mice</span>
###xml 3026 3030 <span type="species:ncbi:10090">mice</span>
###xml 3174 3179 <span type="species:ncbi:10090">mouse</span>
###xml 3285 3289 <span type="species:ncbi:10090">mice</span>
###xml 3330 3334 <span type="species:ncbi:10090">mice</span>
###xml 3500 3504 <span type="species:ncbi:10090">mice</span>
###xml 4768 4772 <span type="species:ncbi:10090">mice</span>
###xml 4798 4802 <span type="species:ncbi:10090">mice</span>
###xml 4957 4961 <span type="species:ncbi:10090">mice</span>
The expression of MHC class II molecules is generally regulated at the transcriptional levels, including the transcription factor IFN regulatory factor (IRF)-1 (28, 29) and the class II transactivator (CIITA), which is the master regulator for MHC class II gene expression (30, 31). It has been shown that IRF-1 is a primary responsible gene of the IFN-gamma response (32). In in vitro studies using human salivary gland (HSG) cells (33), IFN-gamma-induced mRNAs of IRF-1 and CIITA were significantly enhanced by treatment with Tamoxifen (Tam), which is an antagonist of estrogen and can induce RbAp48 (23), or transfection of pCMV-RbAp48 plasmid in the dose-dependent manner (Fig. 5 A), not in MCF-7 cells (human mammary gland cell line; Fig. S5, A and B, available at ). In addition, we next analyzed the IRF-1 promoter activity using RbAp48-transfected HSG cells with and without IFN-gamma by luciferase assay. We observed significantly enhanced IRF-1 promoter activity in RbAp48-transfected HSG cells with IFN-gamma, not in MCF-7 cells (Fig. 5 B). Surprisingly, in RbAp48-Tg mice, a prominent expression of IFN-gamma was detected in salivary and lacrimal epithelial cells besides sporadically positive infiltrating cells of RbAp48-Tg mice, not WT mice (Fig. 5 C). These findings were observed mainly in the MHC class II+ ductal epithelium adjacent to lymphoid infiltrates. Epithelial IFN-gamma expression in the exocrine glands of RbAp48-Tg mice was up-regulated during the course of autoimmune exocrinopathy. Induction of IFN-gamma expression may occur through many different types of stimulation, including cross-linking of cell-surface receptors and stimulation with cytokines, including IL-2, -12, and -18 (34). It has been demonstrated that IFN-gamma synthesis is predominantly induced by stimulation with IL-18 (35). Consistent with a previous study (36), IL-18 expression was observed in salivary epithelial cells in RbAp48-Tg mice, not in WT mice (Fig. 5 D). Confocal analysis revealed that differential expression of IL-18 and IFN-gamma was clearly observed, i.e., IL-18 mainly in the acinar cells and IFN-gamma in the duct cells, within salivary epithelial cells from RbAp48-Tg mice, but not from WT mice (Fig. 5 D). Controls using isotype antibodies were shown in Fig. S4 C. Epithelial IFN-gamma and IL-18 productions were confirmed by flow cytometry using MSG cells without immune cells from RbAp48-Tg, not from WT mice, whereas there was no difference in both IFN-gamma and IL-18 expressions of cLN cells between WT and RbAp48-Tg mice (Fig. 5 E). Although the production of IL-18 in salivary gland cells was detected in a previous study (36), there has been no proof for IFN-gamma production of salivary gland cells in any paper. Therefore, to confirm IFN-gamma production of exocrine glands, detection of IFN-gamma using tissue homogenates was performed. A high concentration of IFN-gamma was detected in the tissue homogenates of lacrimal and salivary glands from RbAp48-Tg mice, compared with that from WT mice, by ELISA (Fig. S6 A). Furthermore, the detection of IFN-gamma mRNA of MSG cells was performed by in situ hybridization using the RNA probe of mouse IFN-gamma gene. A more intense signal for IFN-gamma mRNA in duct cells of salivary glands from RbAp48-Tg mice was observed compared with that from WT mice (Fig. 5 F). As for the expression of BAFF, which is an inducer of IFN-gamma in B cells, the expression of epithelial cells was undetectable in both RbAp48-Tg and WT mice (Fig. S7). In vitro studies using HSG cells demonstrated that the expressions of IL-18, IFN-gamma, and MHC class II (HLA-DR) were observed when treated with Tam or transfected with pCMV-RbAp48, whereas they were inhibited when treated with 17beta-estradiol (E2), caspase 1 inhibitor (Ac-YVAD-CHO; Ci), and siRNA of RbAp48 (si; Fig. 6 A). Confocal analysis confirmed the expression of IL-18 and IFN-gamma in HSG cells treated with Tam or transfected with pCMV-RbAp48 (Fig. 6 B). It is important to note that IL-18 is secreted earlier (by 6 h) than IFN-gamma production and HLA-DR expression (by 12 h) in Tam-stimulated and RbAp48-transfected HSG cells (Fig. S8). The most prominent function of IL-18 is its capacity to act as a potent costimulus for IFN-gamma production (37-39). Indeed, we observed an increase in IFN-gamma production in HSG cells treated with recombinant IL-18 in the dose-dependent manner, but not in MCF-7 cells (Fig. S9, available at ), by ELISA and flow cytometry (Fig. 6 C). Confocal analysis of IFN-gamma production of HSG cells in response to IL-18 together with cytokeratin as an identified marker was shown in Fig. 6 D. Moreover, we found a significant up-regulation of caspase 1 activity in lacrimal and salivary glands from RbAp48-Tg mice relative to that from WT mice (Fig. 6 E). In this regard, we reported previously significantly increased caspase 1 activity in salivary gland tissues from ovariectomized (Ovx) C57BL/6 mice in vivo (22) and Tam-stimulated and RbAp48-transfected HSG cells in vitro (23).
###end p 19
###begin p 20
###xml 0 75 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947; production from salivary epithelial cells stimulated with RbAp48.</bold>
###xml 162 164 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;9</sup>
###xml 167 169 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 198 204 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 564 570 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 793 799 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1076 1082 1019 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1330 1336 1267 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1416 1422 1353 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
###xml 877 880 <span type="species:ncbi:10116">rat</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
###xml 1215 1219 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
###xml 1426 1430 <span type="species:ncbi:10090">mice</span>
###xml 1525 1530 <span type="species:ncbi:10090">mouse</span>
IFN-gamma production from salivary epithelial cells stimulated with RbAp48. (A) IRF-1 and CIITA mRNA expressions of HSG cells stimulated with Tam (approximately10-9-10-7 M) or transfected with pCMV-RbAp48 (approximately0-1 mug) in the presence of IFN-gamma (5 ng/ml) were detected by real-time PCR. Data are shown as means +/- SE (SE) relative to beta-actin mRNA of two independent experiments. *, P < 0.05; **, P < 0.005, versus IFN-gamma (+) Tam 0 M or IFN-gamma (+) pCMV-RbAp48 0 mug. (B) Promoter activity of IRF-1 in HSG and MCF-7 cells transfected with pCMV-RbAp48. Data are shown as means +/- SE (SE) of two independent experiments. *, P < 0.05; **, P < 0.005, versus Mock (C and D) Confocal analysis of IFN-gamma, MHC Class II, CD4, IL-18 or DAPI of salivary gland tissues from WT and RbAp48-TG mice at 32 wk of age. Alexa Fluor 488- or Alexa Fluor 568-conjugated anti-rat IgG were used as the second antibodies. Images are representative of three to five mice. (E) Intracellular IFN-gamma and IL-18 expressions of cLN and MSG (without immune cells) cells from WT and RbAp48-Tg mice at 32 wk of age was detected by flow cytometric analysis. Results are representative and are shown as means +/- SE of three mice of each group in two independent experiments. (F) The expression of IFN-gamma mRNA in salivary gland cells of RbAp48-Tg mice was detected by in situ hybridization. Representative images of WT and RbAp48-Tg mice are shown in two independent experiments. Negative (antisense probe) or positive controls for mouse IFN-gamma RNA probe are shown in Fig. S6 B. Fig. S6 is available at . Bars: (C) 50 mum; (D) 40 mum.
###end p 20
###begin p 21
###xml 120 126 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 0 127 0 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expressions of IL-18, IFN-&#947;, and MHC class II (HLA-DR) in HSG cells when treated with Tam and transfected with pCMV-<italic>RbAp48</italic>.</bold>
###xml 156 158 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;9</sup>
###xml 1321 1327 1287 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1497 1503 1461 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 753 758 <span type="species:ncbi:10090">mouse</span>
###xml 1331 1335 <span type="species:ncbi:10090">mice</span>
###xml 1392 1396 <span type="species:ncbi:10090">mice</span>
###xml 1453 1457 <span type="species:ncbi:10090">mice</span>
###xml 1507 1511 <span type="species:ncbi:10090">mice</span>
Expressions of IL-18, IFN-gamma, and MHC class II (HLA-DR) in HSG cells when treated with Tam and transfected with pCMV-RbAp48. (A) Inhibitory effects of 10-9 M 17beta-estradiol (E) or 10 muM caspase 1 inhibitor (Ci) on RbAp48-induced IL-18, IFN-gamma, and HLA-DR in HSG cells. IL-18 and IFN-gamma of the culture supernatants were detected by ELISA. HLA-DR is shown as mean fluorescence intensity (MFI) by flow cytometric analysis. *, P < 0.05; **, P < 0.005, versus RbAp48-induced. Data are means +/- SD of triplicate samples, and representative of two independent experiments. (B) Tam- or RbAp48-induced IL-18 and IFN-gamma were detected by confocal microscopic analysis. IL-18, IFN-gamma mAbs, and Alexa Fluor 488- or Alexa Fluor 568-conjugated anti-mouse IgG were used. Images are representative of three independent experiments. (C) IFN-gamma secretion or production of HSG cells by the addition of recombinant IL-18 was detected by ELISA or intracellular flow cytometric analysis. Data are representative of three independent experiments. (D) IFN-gamma expression of IL-18-stimulated HSG cells was detected by confocal microscopic analysis together with cytokeratin and DAPI stainings. Images are representative of three independent experiments. (E) Caspase 1 activity of lacrimal, salivary glands, and spleen from RbAp48-Tg mice at 28 wk of age. Data are shown as means +/- SE of four mice in two independent experiments, relative to those of WT mice. *, P < 0.05; **, P < 0.005; WT versus RbAp48-Tg mice. Bars: (B) 20 mum; (D) 50 mum.
###end p 21
###begin title 22
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Transfer of autoimmune exocrinopathy in RbAp48-Tg mice
###end title 22
###begin p 23
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 476 482 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 515 523 515 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 671 672 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 913 916 913 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 982 988 982 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 998 1013 998 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, B and C</xref>
###xml 1103 1107 1103 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 1107 1110 1107 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1181 1185 1181 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 1185 1188 1185 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1195 1210 1195 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, D and F</xref>
###xml 1311 1313 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1422 1428 1422 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1479 1483 1479 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 1483 1486 1483 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1493 1500 1493 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 1621 1627 1621 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1735 1741 1735 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1801 1807 1801 1807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1871 1877 1871 1877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1912 1916 1912 1916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 1916 1919 1916 1919 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2004 2008 2004 2008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 2008 2011 2008 2011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2055 2061 2055 2061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 2150 2154 2150 2154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 2154 2157 2154 2157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2210 2225 2210 2225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, E and G</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1189 1193 <span type="species:ncbi:10090">mice</span>
###xml 1432 1436 <span type="species:ncbi:10090">mice</span>
###xml 1487 1491 <span type="species:ncbi:10090">mice</span>
###xml 1631 1635 <span type="species:ncbi:10090">mice</span>
###xml 1745 1749 <span type="species:ncbi:10090">mice</span>
###xml 1811 1815 <span type="species:ncbi:10090">mice</span>
###xml 1881 1885 <span type="species:ncbi:10090">mice</span>
###xml 1920 1924 <span type="species:ncbi:10090">mice</span>
###xml 2012 2016 <span type="species:ncbi:10090">mice</span>
###xml 2065 2069 <span type="species:ncbi:10090">mice</span>
###xml 2158 2162 <span type="species:ncbi:10090">mice</span>
###xml 2204 2208 <span type="species:ncbi:10090">mice</span>
Because thymic T cell abnormality could not be observed in RbAp48-Tg mice, it is speculated that there may be dysregulation of peripheral tolerance. To know the homeostatic expansion of peripheral T cells from RbAp48-Tg mice, we adoptively transferred CFSE-labeled CD4+ T cells from RbAp48-Tg mice into irradiated syngeneic C57BL/6.Ly5.1 mice and analyzed them 7 d later. As a result, we observed more substantial cell division of the donor CFSE-labeled cLN CD4+ T cells from RbAp48-Tg mice than that from WT mice (Fig. 7 A), indicating that T cells undergoing homeostatic proliferation may provide a basis for autoimmunity (40, 41). This suggests that elicitation of CD4+ T cell-mediated autoreactivity against autoantigen could be the primary pathogenic process that leads to substantial homeostatic expansion. Futhermore, we succeeded in adoptive transfer of autoimmune lesions in the exocrine glands into Rag2-/- mice using cervical lymph node cells, but not spleen cells, from RbAp48-Tg mice (Fig. 7, B and C). Interestingly, these transferred lesions were extremely enhanced in estrogen-deficient Rag2-/- mice treated with ovariectomy (Ovx) compared with the lesions in Sham Rag2-/- mice (Fig. 7, D and F), suggesting that estrogen deficiency accelerates autoimmune exocrinopathy, as previously reported (21, 22). When we examined the adoptive transfer using T cells isolated from cervical lymph nodes and spleen of RbAp48-Tg mice, no inflammatory lesions had developed in Rag2-/- mice (Table I). These data suggest that APCs besides T cells might be required for successful transfer of autoimmune exocrinopathy in RbAp48-Tg mice. Finally, to confirm that MHC class II expression on activated salivary or lacrimal gland cells of RbAp48-Tg mice can drive priming of purified T cells of cLNs from RbAp48-Tg mice to induce autoimmune lesions, the T cells of cLNs from RbAp48-Tg mice were transferred into Ovx-Rag2-/- mice. The autoimmune lesions of salivary and lacrimal glands from the recipient Ovx-Rag2-/- mice transferred with T cells of cLNs from RbAp48-Tg mice were observed, whereas no lesions were found in any organs of the recipient Ovx-Rag2-/- mice transferred with T cells of cLNs from WT mice (Fig. 7, E and G). These results demonstrate that the epithelial cells stimulated through increased RbAp48 because of estrogen deficiency could interact with T cells to induce autoimmunity via loss of local tolerance.
###end p 23
###begin p 24
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transfer of autoimmune lesions from <italic>RbAp48</italic>-Tg mice into <italic>Rag2</italic><sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 514 518 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 518 521 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 748 752 748 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 752 755 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 794 800 794 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 852 856 852 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 856 859 856 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1057 1061 1057 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 1061 1064 1061 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1236 1240 1236 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 1240 1243 1240 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
###xml 1353 1357 <span type="species:ncbi:10090">mice</span>
Transfer of autoimmune lesions from RbAp48-Tg mice into Rag2-/- mice. (A) Homeostatic proliferation of splenic and cLN T cells from WT and RbAp48-Tg mice at 28 wk of age was analyzed at 7 d after transfer into irradiated C57BL/6 mice. Results are representative of four to five mice in two independent experiments. Percentages of divided cells from the second or third division are indicated. (B and C) Spleen cells (5 x 106) or cLN cells (5 x 106) from WT and RbAp48-Tg mice at 30 wk of age were transferred into Rag2-/- mice. At 6 wk after the transfer, the pathology of salivary and lacrimal glands was analyzed. Images are representative of four to five mice. (D) cLN cells from WT and RbAp48-Tg mice were transferred into ovariectomized (Ovx) Rag2-/- mice. (E) T cells of cLNs from WT and RbAp48-Tg mice were transferred into ovariectomized (Ovx) Rag2-/- mice. Images of salivary and lacrimal gland tissues were representative of four to five mice. (F) Severity of inflammatory lesions of salivary and lacrimal glands from sham-operated (Sham) and Ovx-Rag2-/- hosts by transfer of cLN cells were shown as mean grade of lesions. (G) Severity of inflammatory lesions of salivary and lacrimal glands from sham-operated (Sham) and Ovx-Rag2-/- hosts by T cell transfer were shown as mean grade of lesions. Data are shown as means +/- SE of four to five mice. *, P < 0.05, Sham versus Ovx. Bars: (B-E) 100 mum.
###end p 24
###begin p 25
Induction of autoimmune lesions
###end p 25
###begin p 26
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Whole spleen, cLN cells, cLN T cells, or cLN B cells were transferred intravenously into Rag2-/- mice. The host mice were killed 6 wk after transfer. Inflammatory lesions of salivary or lacrimal glands were evaluated by pathological analysis.
###end p 26
###begin title 27
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
IFN-gamma and IL-18 expressions in human SS patients
###end title 27
###begin p 28
###xml 577 578 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 592 593 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 652 653 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 663 664 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 776 782 764 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 983 989 967 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 182 187 <span type="species:ncbi:9606">human</span>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 742 750 <span type="species:ncbi:9606">patients</span>
Although it has been reported that immune cells express some cytokines, it is unclear whether IFN-gamma or IL-18 together with RbAp48 in the epithelial cells of salivary glands from human SS patients are expressed. To confirm our hypothesis that autoimmunity is induced by a breakdown of local tolerance in salivary gland cells with up-regulated RbAp48 because of estrogen deficiency such as menopause, IFN-gamma, IL-18, and RbAp48 expressions were detected by confocal microscopic analysis using human biopsy samples from SS patients and controls. Among 10 SS patients, RbAp48+ and IFN-gamma+ epithelial cells were observed in three samples and RbAp48+ and IL-18+ epithelial cells were observed in four samples. A representative image of SS patients and controls is shown in Fig. 8. Although faint expressions of RbAp48 in the nucleus of salivary epithelial cells were detected in control samples, IL-18 or IFN-gamma together with a prominent expression of RbAp48 was not observed (Fig. 8). Isotype-matched controls of staining for the mAbs were shown in Fig. S10 (available at ).
###end p 28
###begin p 29
###xml 0 89 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947; and IL-18 expressions together with RbAp48 in salivary glands from SS patients.</bold>
###xml 80 88 <span type="species:ncbi:9606">patients</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
IFN-gamma and IL-18 expressions together with RbAp48 in salivary glands from SS patients. The frozen sections of salivary glands from SS patients and controls were stained with IFN-gamma or IL-18 (Alexa Fluor 568; red) and RbAp48 (Alexa Fluor 488; green) mAbs. The nuclei were stained with DAPI. The representative images in controls and SS patients were shown in three independent experiments.
###end p 29
###begin title 30
DISCUSSION
###end title 30
###begin p 31
###xml 286 288 286 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 510 512 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 514 516 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 560 562 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 667 669 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 854 856 848 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 911 913 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 995 997 989 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7</sup>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 1234 1239 <span type="species:ncbi:9606">human</span>
Although MHC class II molecules have been expressed aberrantly on epithelial cells in association with autoimmunity, it remains debatable whether class II molecules are the initiating event or the consequence of the autoimmune attack. For example, certain alleles of class II (mouse I-Ag7) might be particularly good at presenting glutamic acid decarboxylase-65 or insulin peptides to T cells in nonobese diabetic (NOD) mice, thus contributing to recognition and ultimate destruction of pancreatic beta cells (10, 11). Some investigators have proposed that I-Ag7, because of its poor peptide-binding properties, enhances autoimmunity in NOD mice in a global fashion (42). In this case, the beta cell specificity of autoimmunity in this strain and the switch to autoimmune thyroiditis when a class II molecule without these properties is exchanged for I-Ag7 must be controlled by other genetic loci in NOD mice (43). It is possible that the most straightforward explanation for the effects of I-Ag7 is that it predisposes to islet-specific autoimmunity and not system-wide reactivity. Another piece of evidence that the role of MHC class II is antigen-specific is that the class II alleles predisposing toward autoimmunity vary in one human disease to another, indicating that class II alleles act in autoimmunity via specific antigens rather than comprehensively.
###end p 31
###begin p 32
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 353 359 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 498 499 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 505 506 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 512 513 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 525 526 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 623 624 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 628 629 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 644 650 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 704 710 700 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1015 1021 1011 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1208 1209 1200 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1320 1326 1308 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1587 1593 1571 1577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 1824 1826 1804 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 1950 1952 1930 1932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 1954 1956 1934 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 2161 2163 2141 2143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 2448 2450 2428 2430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 2451 2453 2431 2433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 2641 2643 2621 2623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 2974 2976 2950 2952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 2978 2980 2954 2956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 3274 3276 3250 3252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 3278 3280 3254 3256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 3749 3751 3717 3719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 3943 3944 3907 3908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1330 1334 <span type="species:ncbi:10090">mice</span>
###xml 1597 1601 <span type="species:ncbi:10090">mice</span>
###xml 2964 2972 <span type="species:ncbi:9606">patients</span>
We demonstrated in this study that autoimmune exocrinopathy resembling SS developed in almost all RbAp48-Tg mice, and that a high titer of serum autoantibodies against SS-A (Ro), SS-B (La), and 120-kD alpha-fodrin was detected in these Tg mice. We frequently found MHC class II molecule expression on the exocrine gland cells with autoimmune lesions in RbAp48-Tg mice. When we examined whether salivary epithelial cells could act on antigen presentation, we found a large proportion of MHC class II+, CD86+, CD80+, and ICAM-1+ cells primarily observed on cultured MSG cells from Tg mice. Moreover, CFSE-labeled purified CD4+ (105) T cells from RbAp48-Tg mice were capable of responding to MSG cells from RbAp48-Tg mice, whereas anti-MHC class II antibody inhibited these responses. Although it has not been determined whether MHC class II-expressing epithelial cells can function as APCs, those data strongly suggest that the epithelial cells may function as APCs during development of autoimmune exocrinopathy. In RbAp48-Tg mice, a surprisingly prominent expression of epithelial IFN-gamma was detected beside sporadically positive infiltrating cells. These findings were observed mainly in the MHC class II+ ductal epithelium adjacent to lymphoid infiltrates. Epithelial IFN-gamma expression in the exocrine glands of RbAp48-Tg mice was up-regulated during the course of autoimmune exocrinopathy. A previously unknown, multifaceted role of IFN-gamma as regulator of the local immune system, which is termed here local tolerance, is disclosed. As to the mechanism of CIITA induction in RbAp48-Tg mice, our findings demonstrate the essential role of RbAp48-driven stimulation of IFN-gamma production and signaling leading to up-regulation of IRF-1 and CIITA. RbAp48, initially identified as retinoblastoma-binding proteins (44), was characterized as a component of distinct nucleosome-modifying complexes, including the nuclear histone deacetylases (45, 46). Although the functions of the RbAp48-like proteins in these complexes remain undetermined, it was reported that E2F-1 and RbAp48 are physically associated in the presence of Rb and histone deacetylase (47), suggesting that RbAp48 could be involved in transcriptional repression of E2F-responsive genes. Several reports have demonstrated that estrogen may play an inhibitory role on apoptosis in endothelial cells, breast cancer cells, cardiac myocytes, prostate cells, and neuronal cells (48-51). It has been shown that the transcription factor IRF-1 mRNA expression is induced by ICI 182,780 as an antiestrogenic reagent and repressed by estrogens in antiestrogen-sensitive cells (52). We demonstrated the first evidence that IFN-gamma-producing epithelial cells in the exocrine glands function as APCs through the IRF-1-CIITA pathway, resulting in the development of autoimmune exocrinopathy via loss of local tolerance. SS is known to have the most female predominance of >95% among all the autoimmune patients (15, 16). One of the key questions in respect to the pathophysiology of autoimmune diseases is how autoreactivity to particular autoantigens is initiated and maintained under an estrogen-deficient state. Although an important role for T cells in the development of autoimmune disease has been argued (53, 54), it is not known if disease is initiated by a retrained inflammatory reaction to autoantigen. We clarified that epithelial IFN-gamma production is crucial for the initiation of autoimmune reactions between epithelial cells and autoreactive T cells with homeostatic expansion. Our previous study suggests that antiestrogenic actions have a potent effect on the proteolysis of alpha-fodrin autoantigen in the salivary gland through up-regulation of caspase 1 activity (22). These results strongly suggest that RbAp48-mediated activation of caspase 1 leads to the cleavage and activation of IL-18, which may act directly on IFN-gamma production and on effector CD4+ T cells by inducing migration and proliferation. Thus, aberrant expression of MHC class II in the exocrine glands facilitates loss of local tolerance before the development of autoimmune lesions, which is very similar to SS.
###end p 32
###begin p 33
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 290 296 290 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 318 321 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 573 574 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 711 717 711 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 739 742 739 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1086 1092 1082 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 652 657 <span type="species:ncbi:9606">human</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 992 997 <span type="species:ncbi:9606">human</span>
###xml 1001 1009 <span type="species:ncbi:9606">patients</span>
###xml 1096 1100 <span type="species:ncbi:10090">mice</span>
Evidence has been mounting that estrogen deficiency such as menopause is a proinflammatory state, which promotes osteoporosis and atherosclerosis, as well as autoimmunity (55, 56). In vivo and in vitro experiments here, including the induction of autoimmune lesions by T cell transfer from RbAp48-Tg mice into Ovx-Rag2-/- mice and in vitro antigen presentation of the Tg MSG cells to CD4+ T cells, strongly suggests that estrogen deficiency stimulates salivary epithelial cells that are activated via the up-regulation of RbAp48 to present any endogenous autoantigen to CD4+ T cells for the onset of autoimmune lesion in the salivary glands resembling human SS. Our data finds that transfer of cLN T cells from RbAp48-Tg mice into Ovx-Rag2-/- mice leads to autoimmune lesions, consistent with the conclusion that estrogen deficiency leads to the ability of salivary gland epithelial cells to express MHC class II and present any self-antigens. Most importantly, the salivary gland cells from human SS patients express RbAp48 together with IFN-gamma or IL-18, as well as the findings of RbAp48-Tg mice in this work, suggesting that the molecules would be useful for any clinical application.
###end p 33
###begin p 34
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Collectively, our results demonstrate a direct molecular mechanism by which estrogen deficiency induces tissue-specific overexpression of RbAp48 (23), subsequently developing CD4+ T cell-mediated autoimmunity through epithelial IFN-gamma production. Thus, reducing the RbAp48 overexpression is a possible effective therapy in gender-based autoimmune exocrinopathy.
###end p 34
###begin title 35
MATERIALS AND METHODS
###end title 35
###begin title 36
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and histology.
###end title 36
###begin p 37
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 232 237 <span type="species:ncbi:10090">mouse</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 709 714 <span type="species:ncbi:10090">mouse</span>
RbAp48-Tg mice have been previously described (23), and the RbAp48 gene is regulated by lacrimal and salivary gland-specific promoter (57). Rag2-/- mice were obtained from Taconic. All mice were reared in our specific pathogen-free mouse colony, and given food and water ad libitum. The experiments were approved by an animal ethics board of Tokushima University. All organs were removed from the mice, fixed with 4% phosphate-buffered formaldehyde (pH 7.2), and prepared for histological examination. Formalin-fixed tissue sections were subjected to hematoxylin and eosin (H&E) staining, and three pathologists independently evaluated the histology without being informed of the condition of each individual mouse. Histological grading of the inflammatory lesions was done according to the method proposed by White and Casarett (58), as follows: 1 = 1-5 foci composed of >20 mononuclear cells per focus, 2 = >5 such foci, but without significant parenchymal destruction, 3 = degeneration of parenchymal tissue, and 4 = extensive infiltration of the glands with mononuclear cells and extensive parenchymal destruction. Histological evaluation of the salivary and lacrimal glands was performed in a blind manner, and a tissue section from each salivary and lacrimal gland was examined.
###end p 37
###begin title 38
Measurement of fluid secretion.
###end title 38
###begin p 39
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Analysis of the tear and saliva volume of WT and RbAp48-Tg mice was performed according to a previously described method (59).
###end p 39
###begin title 40
Flow cytometric analysis.
###end title 40
###begin p 41
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 215 218 <span type="species:ncbi:10116">Rat</span>
Lymphocytes in spleen, cLN, thymus, and MSG epithelial cells without immune cells (>95% of cells were keratin+) were prepared. Surface markers were identified by mAbs with an EPICS flow cytometer (Beckman Coulter). Rat mAbs to FITC-, PE-, or PE-Cy5-conjugated anti-B220, CD4, MHC class II, CD86, CD80, ICAM1, and CD5 mAbs (eBioscience) were used. Appropriate isotype-matched controls were used, respectively. For detection of T cell activation markers, FITC-conjugated anti-CD25, CD44, CD62L, CD45RB, and CD69 mAbs (eBioscience) were used. Intracellular Foxp3 expression with an Intracellular Foxp3 Detection kit (eBioscience) was performed according to the manufacturer's instructions. Detections of intracellular IFN-gamma or IL-18 were also performed by the same procedure. The data were analyzed with FlowJo FACS Analysis software (Tree Star, Inc.).
###end p 41
###begin title 42
ELISA.
###end title 42
###begin p 43
###xml 85 86 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 271 277 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 695 706 <span type="species:ncbi:3704">horseradish</span>
###xml 821 832 <span type="species:ncbi:3704">horseradish</span>
The amount of mouse IL-2, IFN-gamma, IL-4, and IL-10 in culture supernatants from CD4+ T cells stimulated with anti-TCR mAb (approximately0-1 mug/ml) and anti-CD28 mAb (20 mug/ml; eBioscience), anti-SSA, anti-SSB, and anti-alpha-fodrin autoantibodies of sera from WT and RbAp48-Tg mice and human IL-18 and IFN-gamma from cultured HSG and MCF-7 cells were analyzed by ELISA. In brief, plates were coated with a capture antibody or recombinant proteins (SSA, SSB, and alpha-fodrin), and washed with PBS/0.1% Tween 20. The plates were incubated with diluted culture supernatants or sera. After washing with PBS/0.1% Tween 20 and incubation of biotin-conjugated antibodies for cytokine detection, a horseradish peroxidase-conjugated detection antibody for autoantibody detection was added. After incubation with streptavidin-horseradish peroxidase for cytokine detection, plates were again washed with PBS/0.1% Tween 20 and o-phenylendiamine (Sigma-Aldrich) buffer added. Plates were then analyzed with a microplate reader reading at 490 nm.
###end p 43
###begin title 44
Confocal microscopic analysis.
###end title 44
###begin p 45
###xml 228 234 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 382 387 <span type="species:ncbi:10090">mouse</span>
###xml 415 419 <span type="species:ncbi:9925">goat</span>
###xml 425 431 <span type="species:ncbi:9986">rabbit</span>
###xml 459 465 <span type="species:ncbi:9793">donkey</span>
###xml 471 474 <span type="species:ncbi:10116">rat</span>
###xml 502 509 <span type="species:ncbi:9031">chicken</span>
###xml 515 519 <span type="species:ncbi:9925">goat</span>
###xml 551 557 <span type="species:ncbi:9986">rabbit</span>
###xml 563 567 <span type="species:ncbi:9925">goat</span>
Confocal microscopic analysis using anti-Thy1.2, B220, CD4, CD8, MHC class II, IFN-gamma, CD4 (eBioscience), keratin (LSL CO., LTD), and IL-18 (MBL) antibodies was performed on the frozen sections of salivary glands from WT and RbAp48-Tg mice, and on the cultured cells using Confocal Laser Microscan (LSM 5 PASCAL; Carl Zeiss, Inc.). As the second antibodies, Alexa Fluor 488 anti-mouse IgG (H+L), Alexa Fluor 568 goat anti-rabbit IgG (H+L), Alexa Fluor 488 donkey anti-rat IgG (H+L), Alexa Fluor 488 chicken anti-goat IgG (H+L), and Alexa Fluor 568 rabbit anti-goat IgG (H+L; Invitrogen) were used. The nuclear DNA was stained with DAPI (Invitrogen).
###end p 45
###begin title 46
Cell culture.
###end title 46
###begin p 47
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 603 609 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 735 736 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 870 871 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 927 928 926 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1427 1429 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 1815 1816 1797 1798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 228 231 <span type="species:ncbi:10116">rat</span>
###xml 385 388 <span type="species:ncbi:10116">rat</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 1208 1213 <span type="species:ncbi:9606">human</span>
For the co-culture of MSG with CD4+ T cells, MSG cells were prepared by digestion of collagenase and hyaluronidase, and CD11c+, CD11b+, B220+, NK1.1+, and Thy1.2+ cells were removed by the mAbs and magnetic bead-conjugated anti-rat IgG (Invitrogen). CD4+ T cells from cLNs were purified by mAbs (anti-MHC class II, CD8, CD11b, CD11c, B220, and NK1.1) and magnetic bead-conjugated anti-rat IgG. CFSE-labeled CD4+ T cells were co-cultured with MSG cells for 72 h. Cell division of CD4+ T cells was analyzed by dilution of CFSE through flow cytometry. As for the co-culture with DCs or MSG cells, DCs from RbAp48-Tg or WT mice were enriched using DC collection kit (Invitrogen). After DCs or MSG cells were irradiated (9 Gy), purified CD4+ T cells of cLNs from RbAp48-Tg mice were co-cultured with the DCs or MSG cells for 72 h. The T cells were then pulsed with 0.5 muCi [3H]thymidine per well for the last 12 h of the culture. [3H]thymidine incorporation was evaluated using an automated beta liquid scintillation counter. HSG and MCF-7 cells were cultured in DME containing 10% FBS at 37degreesC. Tam (Wako Pure Chemical), 17beta-estradiol (Wako), 10 muM caspase 1 inhibitor (Sigma-Aldrich), and recombinant human IFN-gamma (R&D Systems) were used for cell cultures. RbAp48 gene inserted into pCMV (2N3T) construct (a gift from D. Trouche, Centre National de la Recherche Scientifique, University of Tolouse, Tolouse, France) (47) was transfected into the cells using FuGENE6 Transfection Reagent (Roche). Small interfering RNA (siRNA) corresponding to coding sequence +136 to +156 of RbAp48 gene was synthesized by Hokkaido System Science: CGAGGAAUACAAAAUAUGGTT (sense), CCAUAUUUUGUAUUCCUCGTT (antisense). When the siRNA was transfected into HSG cells together with GFP plasmid, 73.4% of cells were found to be GFP+ HSG cells by flow cytometric analysis. Furthermore, the relative protein expression of RbAp48 to beta-actin was reduced to approximately80% by the siRNA.
###end p 47
###begin title 48
Real-time quantitative RT-PCR.
###end title 48
###begin p 49
Total RNA was extracted from cultured HSG and MCF-7 cells using ISOGEN (Wako Pure Chemical), and reverse transcribed. Transcript levels of IRF-1, CIITA, and beta-actin were performed using PTC-200 DNA Engine Cycler (Bio-Rad Laboratories) with SYBR Premix Ex Taq (Takara). Primer sequences were as follows: IRF-1, forward 5'-ACCCTGGCTAGAGATGCAGA-3' and reverse 5'-CCTTTTCCCCTGCTTTGTATCG-3'; CIITA, forward 5'-CAGGCAGCAGAGGAGAAGTTCACCATC-3' and reverse 5'-CCGTGAGGATCCGCACCAGTTTGGGG-3'; beta-actin, forward 5'-AAATCTGGCACCACACCTTC-3' and reverse 5'-GAGGCGTACAGGGATAGCA-3'.
###end p 49
###begin title 50
Caspase activity.
###end title 50
###begin p 51
###xml 197 203 196 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
Caspase activities were assayed using Caspase-Family Colorimetric Substrate Set (BioVision, Inc.). In brief, 100 mug cytoplasmic lysates from lacrimal glands, salivary glands, and spleen of WT and RbAp48-Tg mice were incubated with 200 muM Ac-YVAD-pNA (Caspase 1 substrate), at 37degreesC for 1 h. The absorbance of samples was read at 405 nm in a microplate reader.
###end p 51
###begin title 52
Promoter assay.
###end title 52
###begin p 53
###xml 247 253 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
For the measurement of the transcriptional activity of IRF-1, IRF-1 luciferase reporter vector (IRF-1/Luc) was purchased from Panomics. HSG cells plated in a 48-well plate were transiently transfected with 0.1 mug of IRF-1/Luc and 0.1 mug of pCMV-RbAp48 or mock plasmid and 0.05 mug of phRL-TK (Promega Corp.) as an internal control using the FuGENE6. The cells were incubated overnight and subsequently treated with IFN-gamma. After 10 h, the cells were harvested and subjected to a luciferase assay by using a dual-luciferase reporter assay system (Promega Corp.) as per the manufacturer's instructions. Relative luciferase activity was expressed as the fold- increase relative to the activity of untreated controls after normalization to the relative background of Renilla luciferase activity.
###end p 53
###begin title 54
Cell transfer.
###end title 54
###begin p 55
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 424 430 424 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 475 479 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2</italic>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
CFSE-labeled splenic and cLN T cells (5 x 106) from WT and RbAp48-Tg mice were intravenously transferred into irradiated (700 cGy) C57BL/6.Ly5.1 mice. On the seventh day after the transfer, spleen cells were analyzed to measure homeostatic proliferation via CFSE dilution by flow cytometry. For induction of autoimmune lesions, total cells, T cells, or B cells from spleen cells (5 x 106) or cLN cells (5 x 106) from WT and RbAp48-Tg mice were intravenously transferred into Rag2-/- mice. At 6 wk after the transfer, the pathology of all the organs, including salivary and lacrimal glands, was analyzed. In addition, Rag2-/- hosts were ovariectomized (Ovx) or sham operated (Sham). Adoptive cell transfer was performed on the next day after Ovx or Sham.
###end p 55
###begin title 56
In situ hybridization.
###end title 56
###begin p 57
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 232 237 <span type="species:ncbi:10090">mouse</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
Mice were perfused transcardially with saline (0.9%) followed by 4% PFA. The salivary glands were collected and fixed in 4% PFA at 4degreesC for 3 h. 6 mum paraffin-embedded sections were prepared for ISH. The RNA probe (587 bp) of mouse IFN-gamma was produced by RT-PCR using primers (T3, AATTAACCCTCACTAAAGGGACTGGCAAAAGGATGGTGAC; T7, TAATACGACTCACTATAGGGAGATACAACCCCGCAATCAC). Digoxigenin (DIG)-labeled antisense and sense control riboprobes were generated using DIG RNA labeling mix (Roche). The sections were pretreated with 10 mug/ml proteinase K for 10 min at room temperature and then hybridized with 1 mug/ml DIG-labeled probes at 45degreesC for 16 h. DIG was immunodetected with alkaliphosphatase-conjugated anti-DIG antibody. For positive controls, sections of spleen from lipopolysaccaride-injected mice were used. The probe was confirmed with the positive control sections, as shown in Fig. S6 B.
###end p 57
###begin title 58
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human samples.
###end title 58
###begin p 59
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 375 383 <span type="species:ncbi:9606">patients</span>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
###xml 843 848 <span type="species:ncbi:9606">human</span>
###xml 885 891 <span type="species:ncbi:9793">donkey</span>
###xml 897 902 <span type="species:ncbi:10090">mouse</span>
###xml 952 957 <span type="species:ncbi:9606">human</span>
Immunostaining for RbAp48 and IL-18 or IFN-gamma were performed using lip biopsy samples from human SS patients and controls. All samples were obtained from the Tokushima University Hospital, Tokushima, Japan. This study was approved by certification of the ethics board of Tokushima University Hospital. All subjects signed a written informed consent before enrollment. All patients with SS were female, had documented xerostomia and keratoconjunctivitis sicca, and fulfilled the criteria of the Ministry of Health, Labor, and Welfare of Japan for the diagnosis of SS. All patients with SS had focus scores of greater than two in their lip biopsy and all tested positive for autoantibodies against Ro. Analysis was performed under the certification of the ethics board of Tokushima University Hospital. Frozen sections were stained with anti-human RbAp48 mAb (BD) and Alexa Fluor 488 donkey anti-mouse IgG (H+L; Invitrogen) and Biotin-conjugated anti-human IL-18 (MBL) or IFN-gamma (eBioscience) mAbs and Alexa Fluor 568-conjugated streptavidin and analyzed by confocal microscopy. The nuclear DNA was DAPI.
###end p 59
###begin title 60
Statistics.
###end title 60
###begin p 61
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Student's t test was used for statistical analyses.
###end p 61
###begin title 62
Online supplemental material.
###end title 62
###begin p 63
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 502 508 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 609 615 601 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 763 769 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 914 920 898 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RbAp48</italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
###xml 1109 1117 <span type="species:ncbi:9606">patients</span>
Fig. S1 shows T cell phenotypes of thymus from RbAp48-Tg and WT mice. Fig. S2 shows T reg cells of thymus, spleen, and cLN from RbAp48-Tg and WT mice. Fig. S3 shows B1 cells in salivary glands and marginal B cells of spleen and cLN from RbAp48-Tg and WT mice. Fig. S4 shows the purified MSG cells, and images of control staining for the expressions of MHC class II, CD86, CD80, ICAM-1, IFN-gamma, and IL18. Fig. S5 shows IRF-1 and CIITA mRNA of MCF-7 cells stimulated with Tam or transfected with pCMV-RbAp48. Fig. S6 shows IFN-gamma concentration of tissue homogenates of lacrimal, salivary, and spleen from RbAp48-Tg and WT mice, and control sections for in situ hybridization of IFN-gamma mRNA. Fig. S7 shows BAFF expression of salivary glands and spleen from RbAp48-Tg and WT mice. Fig. S8 shows the time courses of IL-18, IFN-gamma, and HLA-DR expressions of HSG cells stimulated Tam or transfected with pCMV-RbAp48. Fig. S9 shows IFN-gamma secretion from MCF-7 in response to IL-18. Fig. S10 shows control staining for RbAp48 expression together with IFN-gamma or IL-18 in salivary glands from human SS patients and controls. The online supplemental material is available at .
###end p 63
###begin title 64
Supplementary Material
###end title 64
###begin title 65
[Supplemental Material Index]
###end title 65
###begin p 66
###xml 238 243 <span type="species:ncbi:9606">human</span>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
The authors thank Ai Nagaoka and Noriko Kino for their technical assistance; Kumio J. Tanaka, Mizue Yamanaka, and Shino Niki of OurGenic Co., Ltd. for analysis by in situ hybridization; and Prof. Noriaki Takeda for analysis of samples of human SS patients.
###end p 66
###begin p 67
This work was supported in part by a Grant-in-Aid for Scientific Research (nos. 17109016, and 17689049) from the Ministry of Education, Science, Sport, and Culture of Japan, and from the Uehara Memorial Foundation.
###end p 67
###begin p 68
The authors have no conflicting financial interests.
###end p 68

